| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chairman And CEO | Chief Executive Officer
1 company
Trieu Vuong is a Chairman And CEO at Oncotelic Therapeutics, Inc.. Recent SEC Form 4 filings include 6 buys and 0 sells.
Estimated insider holdings value: $4.7M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Dec 6, 2022 | OTLC Oncotelic Therapeutics, Inc. | Chairman And CEO | Buy | 120,000 | $0.05 | $6,000.00 | +0.1% | |
| Nov 22, 2022 | OTLC Oncotelic Therapeutics, Inc. | Chairman And CEO | Buy | 70,000 | $0.08 | $5,600.00 | - | |
| Sep 26, 2022 | OTLC Oncotelic Therapeutics, Inc. | Chairman And CEO | Buy | 20,000 | $0.07 | $1,360.00 | - | |
| Aug 25, 2022 | OTLC Oncotelic Therapeutics, Inc. | Chairman And CEO | Buy | 80,000 | $0.08 | $6,560.00 | - | |
| Nov 19, 2020 | OTLC Oncotelic Therapeutics, Inc. | Chief Executive Officer | Buy | 50,500 | $0.19 | $9,595.00 | +0.3% | |
| Mar 26, 2020 | OTLC Oncotelic Therapeutics, Inc. | Chief Executive Officer | Buy | 3,000 | $0.12 | $360.00 | - |